Terug
Dagbereik
€ 96,14
€ 98,80
52-Weeksbereik
€ 29,17
€ 124,49
Volume
1.366.459
50D / 200D Gem.
€ 103,15
/
€ 64,57
Vorige Slotkoers
€ 95,78
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -16,9 | 0,4 |
| P/B | 11,7 | 2,9 |
| ROE % | -58,1 | 3,7 |
| Net Margin % | — | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,1 | 0,2 |
Belangrijkste Punten
Debt/Equity of 0,10 — conservative balance sheet
Negative free cash flow of -913,73M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-58,07%
ROIC-49,54%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
0,10
Current Ratio7,14
Interest Coverage-48,80
Waardering
P/E Ratio
-16,93
P/B Ratio11,74
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -1,13B |
| ROE | -58,07% | ROA | -48,05% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -913,73M |
| ROIC | -49,54% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,10 | Current Ratio | 7,14 |
| Interest Coverage | -48,80 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -16,93 | P/B Ratio | 11,74 |
| P/S Ratio | N/A | PEG Ratio | -0,20 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 19,15B | Enterprise Value | 18,92B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 11,58M | 35,38M | 29,39M |
| Net Income | -1,13B | -600,09M | -436,37M | -248,71M | -187,09M |
| EPS (Diluted) | -5,95 | -3,58 | -3,86 | -3,08 | -2,47 |
| Gross Profit | -16,56M | 0,0 | 11,58M | 35,38M | 29,39M |
| Operating Income | -1,18B | -689,52M | -487,19M | -258,28M | -188,01M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2,35B | 2,56B | 2,06B | 811,93M | 737,99M |
| Total Liabilities | 723,21M | 293,10M | 235,51M | 126,74M | 135,42M |
| Shareholders' Equity | 1,63B | 2,27B | 1,83B | 685,19M | 602,57M |
| Total Debt | 158,70M | 135,84M | 87,94M | 64,21M | 66,63M |
| Cash & Equivalents | 383,75M | 543,06M | 696,15M | 161,41M | 108,50M |
| Current Assets | 2,08B | 2,33B | 1,88B | 660,19M | 589,77M |
| Current Liabilities | 290,42M | 163,91M | 143,85M | 61,98M | 60,35M |